Health-related quality-of-life results from the phase 3 OPTIMISMM study:pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma

Year of publication

2020

Authors

Weisel, Katja; Dimopoulos, Meletios; Moreau, Philippe; Yagci, Munci; Larocca, Alessandra; Kanate, Abraham S.; Vural, Filiz; Cascavilla, Nicola; Basu, Supratik; Johnson, Peter; Byeff, Peter; Hus, Marek; Rodriguez-Otero, Paula; Muelduer, Ercan; Anttila, Pekka; Hayden, Patrick J.; Krauth, Maria-Theresa; Lucio, Paulo; Ben-Yehuda, Dina; Mendeleeva, Larisa

Organizations and authors

University of Helsinki

Anttila Pekka

Helsinki University Hospital

Anttila Pekka

Publication type

Publication format

Article

Parent publication type

Journal

Article type

Original article

Audience

Scientific

Peer-reviewed

Peer-Reviewed

MINEDU's publication type classification code

A1 Journal article (refereed), original research

Publication channel information

Journal/Series

Leukemia & lymphoma

Parent publication name

Leukemia & lymphoma

Volume

Issue

Pages

1850-1859

ISSN

1042-8194

Publication forum

62610

Publication forum level

Open access

Open access in the publisher’s service

Self-archived

Yes

Other information

Fields of science

Cancers

Keywords

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Publication country

United Kingdom

Internationality of the publisher

International

Language

English

International co-publication

Yes

Co-publication with a company

DOI

10.1080/10428194.2020.1747066

The publication is included in the Ministry of Education and Culture’s Publication data collection

Yes